Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1992-9-29
|
pubmed:abstractText |
Previous studies of patients with thromboembolic disease have revealed an association either with hereditary anticoagulant protein deficiencies or with defects in the fibrinolytic system. To obtain a more comprehensive picture and to investigate which analyses are useful in the evaluation of such patients, we have performed an extensive laboratory investigation in 439 individuals with thromboembolic disease. Anticoagulant protein deficiencies were found in 24 patients. Deficiencies of protein C (n = 10) and protein S (n = 9) were most common followed by deficiencies of antithrombin III (n = 3) and plasminogen (n = 2). Six of the nine protein S deficient patients demonstrated a selective deficiency of free protein S with normal total protein S concentrations. To diagnose protein C and S deficiencies among the 201 patients receiving oral vitamin K antagonists, the concentrations of protein C and S were compared with the mean concentration of several other vitamin K-dependent proteins. One protein C and three protein S deficiencies were identified among the treated patients. The number of protein C deficiencies found in this group was significantly lower than the number found among untreated patients. Although fewer protein S deficiencies were also identified among the treated patients, than in the untreated group, the difference was not statistically significant. The results suggest that protein C deficiencies went undetected in the treated group and that oral anticoagulant therapy should be discontinued before efforts to diagnose protein C deficiency are made. We found no cases with heparin cofactor II deficiency. Lupus anticoagulant was present in 10 patients.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0340-6245
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7-13
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1514176-Adolescent,
pubmed-meshheading:1514176-Adult,
pubmed-meshheading:1514176-Aged,
pubmed-meshheading:1514176-Aged, 80 and over,
pubmed-meshheading:1514176-Blood Coagulation,
pubmed-meshheading:1514176-Blood Proteins,
pubmed-meshheading:1514176-Female,
pubmed-meshheading:1514176-Fibrinogen,
pubmed-meshheading:1514176-Fibrinolysis,
pubmed-meshheading:1514176-Humans,
pubmed-meshheading:1514176-Lupus Coagulation Inhibitor,
pubmed-meshheading:1514176-Male,
pubmed-meshheading:1514176-Middle Aged,
pubmed-meshheading:1514176-Thromboembolism
|
pubmed:year |
1992
|
pubmed:articleTitle |
Thromboembolic disease--critical evaluation of laboratory investigation.
|
pubmed:affiliation |
Department of Clinical Chemistry, University of Lund, Malmö General Hospital, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|